Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

SER holding history

Serina Therapeutics, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SER overviewAll 13F holders of SERFull Q2 2026 holdings

Shares (Q2 2026)
1,347
Value
$2.61K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of SER by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,347$2.61K<0.1%+1,342+26,840.0%AddedHolders
Q1 20265$10<0.1%−428−98.8%ReducedHolders
Q4 2025433$829<0.1%−3,033−87.5%ReducedHolders
Q3 20253,466$18.6K<0.1%+3,465+346,500.0%AddedHolders
Q2 20251$6<0.1%−746−99.9%ReducedHolders
Q1 2025747$4.24K<0.1%−3,062−80.4%ReducedHolders
Q4 20243,809$19.1K<0.1%+3,808+380,800.0%AddedHolders
Q3 20241$7<0.1%−1,026−99.9%ReducedHolders
Q2 20241,027$9.84K<0.1%+1,022+20,440.0%AddedHolders
Q1 20245$67<0.1%−13−71.7%ReducedConverted for a 1-for-35 splitHolders
Q4 2023618$238<0.1%+383+163.0%AddedHolders
Q3 2023235$160<0.1%−5,436−95.9%ReducedHolders
Q2 20235,671$5.06K<0.1%+5,636+16,102.9%AddedHolders
Q1 202335$23<0.1%−13,467−99.7%ReducedHolders
Q4 202213,502$7.43K<0.1%+13,467+38,477.1%AddedHolders
Q3 202235$00.0%00.0%UnchangedHolders
Q2 202235$00.0%00.0%UnchangedHolders
Q1 202235$00.0%−15,699−99.8%ReducedHolders
Q4 202115,734$17.0K<0.1%+15,659+20,878.7%AddedHolders
Q3 202175$00.0%+40+114.3%AddedHolders
Q2 202135$00.0%−1,982−98.3%ReducedHolders
Q1 20212,017$4.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.